Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Safety, Tolerability and Pharmacokinetics of Single and Multiple Administration of Injectable PEG-Irinotecan (JK-1201I) in Patients with Malignant Solid Tumor

NCT04366648 is registered in ClinicalTrials.gov with JenKem Technology Co., Ltd. as lead sponsor.

NCT NCT04366648
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04366648 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Safety, Tolerability and Pharmacokinetics of Single and Multiple Administration of Injectable PEG-Irinotecan (JK-1201I) in Patients with Malignant Solid Tumor
Lead sponsor
JenKem Technology Co., Ltd.
Phase
Phase 1
Overall status
Completed
Start date
May 4, 2018
Completion date
March 31, 2021
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor